LQDA - Liquidia Corporation Annual Revenue Growth (Last Twelve Months)

Brandmark of Liquidia Inc. (LQDA)

Liquidia Corporation (LQDA) possesses significant pricing power thanks to its unique PRINT technology for lung therapy. This TTM year-over-year revenue chart visualizes income dynamics, where the value 798.40 captures this metric. Business stability relies on the patent protection of inhalation systems. A high retention rate of specialized engineers and scientists ensures the preservation of the company's key competencies.

Liquidia (LQDA): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Liquidia Technologies (LQDA) - metric breakdowns and financial figures

Summary company analytics:LQDA Liquidia Technologies
Signature product of Liquidia Corp

This indicator recalculates the percentage change in revenue over the last 12 months on a daily basis, eliminating time lags between quarterly reports. For Liquidia Corporation (LQDA), whose drugs exhibit inelastic demand, this trend reflects commercialization success regardless of market cycles. By analyzing the TTM year-over-year revenue growth rate, an investor assesses the effectiveness of business expansion. Steady growth confirms the resilience of fundamental positions and the reliability of patent protection.

Who Liquidia Corporation competes with

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|GLPG: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ANIP (ANI Pharmaceuticals, Inc.)|Annual Revenue Growth (Last Twelve Months) MannKind Corp (MNKD)|AMPH: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) TBPH|AQST (Aquestive Corp) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) scPharmaceuticals Inc. (SCPH)|Revenue Growth YoY (Last 12 Months) TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)